Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.

Breast cancer is the most common cancer and the second leading cause of cancer death in industrialized countries. Systemic treatment of breast cancer is effective at the beginning of therapy. However, after a variable period of time, progression occurs due to therapy resistance. Artesunate, clinical...

Full description

Bibliographic Details
Main Authors: Beatrice Bachmeier, Iduna Fichtner, Peter H Killian, Emanuel Kronski, Ulrich Pfeffer, Thomas Efferth
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21637790/?tool=EBI